Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
ARYA Atherosclerosis|December 24, 2024
Association between ST-segment changes in lead aVR and angiographic findings, syntax score, short-term and intermediate outcomes in patients with acute coronary syndrome: A pilot studyAfshin Amirpour, Hosein Masoumi, Masoumeh Sadeghi, et al.
Indian Heart Journal|July 15, 2024
Anticoagulant and antiplatelet treatment effects on the incidence of major cardiovascular events in patients with coronary artery ectasia: An updated systematic reviewAfshin Amirpour, Reihaneh Zavar, Manizheh Danesh, et al.
Journal of Cardiothoracic Surgery|July 4, 2026
The lowest mitral valve area successfully treated by PTMC: a rare caseMohammad Hadi Mansouri, Mohammad Hashemi Jazi, Bashir Najafabdian, et al.
Current Problems in Cardiology|June 22, 2021
Effect of Beetroot Consumption on Serum Lipid Profile: A Systematic Review and Meta-AnalysisAfshin Amirpoor, Reihaneh Zavar, Atefeh Amerizadeh, et al.
Health Science Reports|June 12, 2024
Assessment of lytic therapy effect in patients with intermediate-high risk pulmonary embolism for prevention of chronic thromboembolic pulmonary hypertension: A randomized, double-blind trialPejman Mansouri, Amir Mohsen Rashidi, Mohammad Hadi Mansouri, et al.
Critical Pathways in Cardiology|March 3, 2022
Comparison of Pulmonary Emboli Management Between Pulmonary Emboli Response Team and the Conventional Method: The First Study From IranMohammad Hadi Mansouri, Farid Esmaeili, Alireza Khosravi, et al.
Thrombosis Journal|July 19, 2024
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trialPejman Mansouri, Zahra Azamian Jazi, Mohammad Hadi Mansouri, et al.
ARYA Atherosclerosis|August 22, 2024
The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysisAfshin Amirpour, Mohammad Amin Behjati, Reihaneh Zavar, et al.
Clinical Cardiology|September 18, 2023
Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double-blind placebo-controlled trial (EMPT-ANGINA Trial)Mohammad Hadi Mansouri, Pejman Mansouri, Masoumeh Sadeghi, et al.
ARYA Atherosclerosis|June 17, 2024
Apixaban, a Novel Oral Anticoagulant, Use to Resolute Arterial Patency in Radial Artery Occlusion Due to Cardiac Catheterization; A Pilot Randomized Clinical TrialAfshin Amirpour, Reihaneh Zavar, Amir Seifipour, et al.
Pageof 4